Clinical Trial Update: Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China [Phase 3]

View source ↗

Summary

Phase 3 trial in China comparing duloxetine to placebo for diabetic peripheral neuropathic pain has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Painful Diabetic Neuropathy

Drugs mentioned

• Cymbalta (duloxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetic Neuropathies | Phase 3 | Status: COMPLETED | Results posted: 2009-06-02